Tong Ren Tang Medical and Health (2667.HK), a subsidiary of Tong Ren Tang Group engaged in traditional Chinese medicine healthcare services, will conduct its IPO from March 20 to 25, planning to issue 110 million H shares, with 10% available for public offering in Hong Kong. The offering price ranges from HKD 7.3 to HKD 8.3, aiming to raise nearly HKD 900 million. As of last Friday (23rd) evening, Tong Ren Tang Medical and Health has received HKD 250 million in margin subscriptions, with the public offering amounting to HKD 89.77 million, oversubscribed by 1.8 times.

The minimum investment for Tong Ren Tang Medical and Health is 500 shares, with an entry fee of HKD 4,191.9. The company expects to be listed for trading on March 30. China International Capital Corporation is the sponsor.

Background

Beijing Tong Ren Tang Medical and Health Investment Co., Ltd. is a strategically focused subsidiary of Tong Ren Tang on traditional Chinese medicine healthcare services in China, providing comprehensive traditional Chinese medicine healthcare services to individual clients, standardized management services to institutional clients, and various health products and other products. As of March 10, 2026, the group has established a tiered traditional Chinese medicine healthcare service network, including 12 self-owned offline medical institutions and one internet hospital, as well as 12 offline managed medical institutions. Leveraging the well-known brand "Tong Ren Tang" and high-quality pharmaceuticals, the group has accumulated and integrated a large amount of online and offline medical resources